In Vivo Dynamic of Amyloid Induced Dystrophic Neurites
About the Research Project
Program
Award Type
Standard
Award Amount
$100,000
Active Dates
April 01, 2004 - March 31, 2006
Grant ID
A2004240
Summary
In AD, the appearance of dystrophic or degenerating neuritis, which are thought to disrupt neuronal function, correlates with the clinical severity of dementia. However, it remains unknown whether the damage to these neuronal structures is static, dynamic or possibly reversible. Dr. Brendza is analyzing neuritic plaques in the brains of living transgenic mice that develop amyloid plaques and AD-like pathology. Amyloid-associated dystrophic neurites, as well as unaffected neuron structures, can be visualized in these animals by their inherent fluorescence. Dr. Brendza is using this system to investigate whether dystrophic neurites undergo dynamic changes over time and to determine if treatments that remove amyloid will reverse the neuronal damage. It is hoped that this research will yield new insight into the dynamic nature of amyloid toxicity and help scientists understand whether removing existing amyloid or sequestering diffusible toxic forms of amyloid-beta peptide is a valid target for the treatment of Alzheimer’s disease.
Related Grants
Alzheimer's Disease Research
Mechanisms of Inhibitory Neuron Vulnerability to Alzheimer’s Disease
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Emiliano Zamponi, PhD
Current Organization
Columbia University
Mechanisms of Inhibitory Neuron Vulnerability to Alzheimer’s Disease
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Emiliano Zamponi, PhD
Current Organization
Columbia University
Alzheimer's Disease Research
Targeting Brain Cell Miscommunication to Restore Memory in Alzheimer’s Disease
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Amira Latif-Hernandez, PhD
Current Organization
Stanford University
Targeting Brain Cell Miscommunication to Restore Memory in Alzheimer’s Disease
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Amira Latif-Hernandez, PhD
Current Organization
Stanford University
Alzheimer's Disease Research
Progranulin as a Potential Therapeutic Target for Alzheimer's Disease
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Andrew Nguyen, PhD
Current Organization
Saint Louis University
Progranulin as a Potential Therapeutic Target for Alzheimer's Disease
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Andrew Nguyen, PhD
Current Organization
Saint Louis University